ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Data Sources  |  Help
Search
HC3.A Immunization: Percentage of children ages 19–35 months vaccinated for selected diseases by poverty statusa and race and Hispanic origin, b 1996–2012

excel icon HC3A Excel Table

  Total Below 100% poverty 100% poverty and above
Characteristic 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009c 2010 2011 2012 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009c 2010 2011 2012 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009c 2010 2011 2012
Total
Combined series (4:3:1:3:3:1:4)d 63.6 70.2 68.5 68.4 60.7 67.2 63.6 63.4 64.8 71.6 71.6 71.6
Combined series (4:3:1:3:3:1)e 65.5 72.5 76.0 76.1 76.9 77.4 76.1 69.9 74.9 77.6 61.6 69.7 72.6 73.9 73.4 75.0 72.4 68.4 73.5 75.2 66.3 73.6 77.4 77.2 78.3 78.2 77.7 70.4 75.5 79.2
Combined series (4:3:1:3:3)f 67.7 68.5 72.7 73.2 72.8 73.7 74.8 79.4 80.9 80.8 80.5 80.1 78.2 71.9 76.8 61.4 63.6 67.8 68.3 67.2 68.0 69.3 75.0 76.8 77.4 76.3 76.9 74.1 69.5 75.0 69.9 70.7 74.8 75.3 74.9 75.2 76.2 81.3 82.8 82.5 82.2 81.4 80.0 72.7 77.7
Combined series (4:3:1:3)g 76.4 76.2 79.2 78.4 76.2 77.2 77.5 81.3 82.5 82.4 82.1 81.8 79.6 73.4 78.8 81.9 76.0 68.9 70.7 74.1 73.3 70.5 71.5 71.8 76.2 78.0 79.2 77.8 78.8 75.4 70.6 76.4 78.6 71.5 79.2 78.9 81.5 80.7 78.3 78.9 79.0 83.3 84.6 84.1 83.9 82.9 81.4 74.4 79.8 84.0 78.9
DTP (4 doses or more)h 81.1 81.5 83.9 83.3 81.7 82.1 81.6 84.8 85.5 85.7 85.2 84.5 85.0 83.9 84.4 84.6 82.5 73.9 75.8 79.5 78.5 76.2 76.5 75.4 79.7 81.2 81.8 80.8 81.1 76.8 80.1 80.8 81.0 78.5 83.6 83.9 86.1 85.4 83.5 83.6 83.5 86.8 87.4 87.4 86.9 85.9 86.5 85.7 86.1 86.8 85.0
Polio (3 doses or more)i 91.0 90.7 90.8 89.6 89.5 89.4 90.2 91.6 91.6 91.7 92.8 92.6 93.6 92.8 93.3 93.9 92.8 87.7 89.3 89.9 87.4 86.9 87.4 88.3 89.1 89.8 89.7 91.9 91.9 91.2 92.0 92.4 93.6 91.8 92.0 91.5 91.7 90.5 89.9 90.1 90.6 92.5 92.2 92.4 93.1 92.8 94.0 93.3 93.6 94.2 93.4
MMR (1 dose or more)j 90.6 90.4 92.0 91.5 90.5 91.4 91.6 93.0 93.0 91.5 92.3 92.3 92.1 90.0 91.5 91.6 90.8 87.2 85.7 90.1 90.0 88.9 89.1 90.2 92.0 91.3 89.3 90.9 91.3 90.2 88.8 91.3 91.3 89.9 91.9 92.0 93.1 92.4 90.9 91.9 91.9 93.4 93.5 92.1 93.0 92.6 91.5 90.6 91.4 91.7 91.4
Hib (3 doses or more)k 91.4 92.5 93.4 93.5 93.4 93.0 93.1 93.9 93.5 93.9 93.4 92.6 90.9 83.6 90.4 94.0 93.3 86.9 89.5 91.1 90.8 90.1 89.6 90.1 91.1 91.7 91.9 91.1 91.0 85.4 82.0 88.1 92.7 93.7 93.1 94.1 94.5 95.0 94.5 94.2 93.9 95.0 94.4 94.6 94.2 93.1 91.9 84.3 91.4 95.3 94.3
Hepatitis B (3 doses or more) 81.8 83.6 87.0 88.1 90.3 88.9 89.9 92.4 92.4 92.9 93.3 92.7 93.5 92.4 91.8 91.1 89.7 78.0 80.7 85.3 86.5 87.3 86.5 87.7 91.1 91.4 91.4 92.7 92.1 90.7 92.3 91.5 91.8 89.4 83.2 84.9 87.7 89.0 91.4 89.5 90.3 93.2 92.8 93.5 93.5 92.9 93.9 92.7 92.0 91.2 89.8
Varicella (1 dose or more)l 12.2 25.8 43.2 57.5 67.8 76.3 80.6 84.8 87.5 87.9 89.2 90.0 90.7 89.6 90.4 90.8 90.2 5.4 16.9 40.5 55.4 63.5 74.0 78.9 84.4 86.4 87.3 88.3 89.2 87.5 89.0 89.6 90.2 89.7 15.3 29.1 44.1 58.2 69.2 77.1 80.9 85.0 87.5 87.7 90.0 90.1 90.4 90.2 90.6 90.9 90.6
PCV (3 doses or more)m 40.8 68.1 73.2 82.8 86.9 90.0 92.8 92.6 92.6 93.6 92.3 33.2 62.2 69.0 78.3 84.1 89.0 88.5 91.2 91.1 93.4 90.7 43.4 70.6 75.3 84.4 88.0 90.3 93.7 93.5 93.5 94.0 93.4
PCV (4 doses or more)m 53.7 68.4 75.3 80.1 80.4 83.3 84.4 81.9 44.6 61.7 72.8 72.7 74.8 78.7 80.6 76.7 57.1 71.1 76.3 83.1 83.2 85.6 86.9 85.3
Hepatitis A (2 doses or more)n 40.4 46.6 49.7 52.2 53.0 39.7 47.3 51.0 50.7 49.4 40.8 46.2 49.1 53.4 55.4
Rotavirus (2 doses or more)o 43.9 59.2 67.3 68.6 37.7 51.5 61.1 63.0 47.1 62.9 71.1 72.5
White, non-Hispanic
Combined series (4:3:1:3:3:1:4)d 64.1 69.9 68.8 69.3 61.7 63.8 59.8 58.2 64.5 71.3 71.8 72.1
Combined series (4:3:1:3:3:1)e 66.2 73.9 77.2 76.0 77.8 77.5 75.3 69.2 73.6 77.3 58.9 69.2 71.6 70.3 69.0 69.8 67.7 67.7 69.9 72.8 67.0 74.5 78.0 77.2 78.9 78.5 76.8 69.4 74.5 78.9
Combined series (4:3:1:3:3)f 68.9 70.4 75.6 75.6 76.0 75.2 77.7 82.5 83.3 82.1 82.2 81.0 77.8 71.9 76.1 59.3 64.3 71.8 70.9 69.8 67.7 70.0 77.4 76.5 76.3 74.1 73.0 70.0 70.1 72.6 70.5 71.4 76.1 76.3 77.0 76.2 78.4 83.1 84.3 83.4 83.1 82.0 79.3 72.1 77.1
Combined series (4:3:1:3)g 78.5 78.7 82.2 81.0 79.4 78.8 80.2 84.3 85.1 83.6 83.9 82.6 79.3 73.9 78.2 82.0 76.8 68.0 71.8 77.3 75.7 72.9 71.3 71.8 78.9 77.6 77.5 75.2 74.9 71.9 72.0 73.8 76.7 66.3 80.4 80.2 83.1 81.8 80.4 78.9 81.0 85.0 86.2 84.8 84.9 83.5 80.7 74.1 79.3 83.7 79.6
DTP (4 doses or more)h 82.7 83.9 86.6 85.5 84.3 83.5 84.4 87.5 87.7 87.1 86.6 85.3 85.0 85.8 84.5 85.0 83.6 72.4 76.0 81.5 81.0 78.0 74.6 74.6 82.0 80.5 81.4 78.0 77.0 76.4 81.2 79.2 78.6 74.9 84.7 85.4 87.6 86.3 85.2 84.6 85.5 88.1 88.8 88.1 87.6 86.3 83.6 86.6 85.9 87.1 85.7
Polio (3 doses or more)i 91.9 91.5 92.2 90.3 90.6 90.1 91.2 93.0 92.1 91.4 93.3 92.6 93.6 93.3 93.2 93.9 93.0 88.2 90.3 90.9 87.7 87.7 87.4 88.0 90.8 88.3 87.4 90.1 86.1 90.2 92.0 91.6 92.4 91.3 92.5 92.0 92.6 90.8 90.9 90.5 91.5 93.3 92.6 92.3 93.6 93.5 91.9 93.5 93.6 94.4 93.4
MMR (1 dose or more)j 91.4 91.4 93.1 92.4 91.5 91.7 92.6 93.2 93.5 91.4 92.8 92.1 91.3 90.8 90.6 91.1 90.9 85.1 84.3 90.4 90.3 88.4 87.2 90.4 89.7 89.9 86.7 87.7 88.3 92.3 89.7 89.7 89.3 89.6 92.5 92.7 93.7 92.8 91.6 92.2 92.9 93.5 94.1 92.1 93.5 92.4 91.9 91.0 90.9 91.5 91.3
Hib (3 doses or more)k 92.8 93.9 95.0 94.8 94.7 94.2 94.1 95.1 94.7 94.2 94.1 92.9 90.8 82.9 90.3 94.1 93.7 87.4 89.9 92.2 92.5 92.2 89.2 88.4 90.9 92.1 89.4 87.9 86.7 86.0 80.1 86.4 91.0 91.1 93.7 94.7 95.5 95.2 95.1 94.7 94.7 95.7 95.1 95.1 94.8 93.8 91.1 83.3 91.1 95.2 94.5
Hepatitis B (3 doses or more) 82.1 84.6 88.3 88.9 91.4 89.6 90.9 93.2 93.0 93.1 93.8 92.5 93.4 92.3 91.4 90.3 89.3 76.4 80.4 87.2 87.8 87.8 86.0 85.9 90.6 91.6 90.2 91.7 87.8 90.5 91.3 91.4 89.6 90.0 83.3 84.9 88.3 89.0 91.9 89.9 91.5 93.6 93.1 93.6 94.0 93.2 93.4 92.6 91.6 90.8 89.0
Varicella (1 dose or more)l 14.5 27.5 41.9 56.0 66.4 74.7 79.4 83.8 86.5 86.1 88.7 89.2 89.8 89.2 88.9 89.6 89.8 6.4 16.5 37.5 50.7 58.4 67.1 75.0 79.5 83.7 82.3 83.2 85.1 89.9 87.4 86.3 87.1 89.6 16.3 29.3 42.8 56.6 67.8 75.7 80.2 84.6 86.9 86.6 89.4 89.8 91.1 89.8 89.6 90.1 89.8
PCV (3 doses or more)m 43.5 70.9 75.3 83.2 87.2 89.8 92.8 93.2 92.8 93.4 92.7 31.3 58.8 65.7 76.4 79.5 84.9 89.8 90.6 90.0 91.9 89.0 45.6 72.7 77.1 84.3 88.4 90.4 92.2 93.8 93.5 94.0 93.7
PCV (4 doses or more)m 57.3 70.9 76.6 81.4 83.4 84.2 85.3 83.5 46.6 60.0 69.4 72.8 77.0 76.0 77.5 74.2 59.3 72.4 77.6 80.6 84.7 86.3 87.6 86.0
Hepatitis A (2 doses or more)n 37.6 46.2 45.8 50.0 52.6 31.1 43.1 44.3 45.0 47.3 39.1 46.7 46.5 51.9 54.3
Rotavirus (2 doses or more)o 46.4 60.2 68.3 70.5 35.8 47.2 57.4 59.8 48.5 63.1 71.5 73.5
Black, non-Hispanic
Combined Series (4:3:1:3:3:1:4)d 58.2 66.9 63.7 64.8 55.1 65.0 61.0 62.7 62.8 69.2 68.0 68.5
Combined series (4:3:1:3:3:1)e 61.7 68.4 70.9 76.3 73.8 75.3 72.7 66.6 74.5 75.3 59.3 63.7 68.1 73.5 71.7 74.4 70.2 63.6 73.7 73.5 62.1 71.9 74.6 80.1 76.8 76.5 74.9 71.2 75.9 77.9
Combined series (4:3:1:3:3)f 66.8 65.6 66.6 69.4 68.2 67.1 67.7 73.0 74.5 79.3 76.7 77.5 74.2 67.9 75.7 61.3 63.8 66.9 66.9 66.8 65.0 65.9 68.9 72.0 75.8 74.0 75.9 71.0 63.8 74.5 71.9 69.5 67.5 72.9 69.5 68.6 68.3 76.8 78.2 83.0 80.4 79.6 77.3 73.1 77.4
Combined series (4:3:1:3)g 74.2 72.8 72.9 73.8 70.6 71.4 70.7 75.2 76.0 80.5 78.4 79.5 75.8 68.9 78.0 78.9 72.5 69.3 71.1 71.9 72.4 68.5 68.7 68.4 70.2 73.8 76.8 75.8 77.9 72.7 65.0 76.3 74.9 71.1 79.1 76.5 74.1 76.7 72.2 74.1 71.7 78.8 79.6 83.8 81.9 82.0 78.6 74.0 80.1 83.9 75.1
DTP (4 doses or more)h 79.0 77.2 77.3 79.0 76.4 76.3 75.8 79.9 79.5 84.0 81.2 82.3 80.1 78.6 83.7 81.3 79.6 74.3 75.9 77.0 77.9 74.5 74.2 73.5 74.6 77.8 79.7 78.8 81.0 82.2 75.5 81.3 78.0 77.0 83.3 80.0 78.8 82.5 78.0 78.1 77.3 83.9 82.8 87.5 84.8 84.2 87.7 83.6 87.1 85.9 84.0
Polio (3 doses or more)i 90.1 89.1 87.8 87.0 86.8 84.9 87.4 89.2 90.4 91.0 90.4 91.1 91.5 90.9 94.0 93.9 92.9 86.8 89.2 88.3 86.2 85.1 84.3 87.0 86.0 89.5 89.0 90.4 91.2 92.5 89.8 92.5 93.5 91.5 92.6 90.5 86.9 88.4 87.1 86.1 87.1 91.4 91.1 92.6 91.4 91.3 96.3 94.0 95.1 94.7 94.6
MMR (1 dose or more)j 89.7 89.0 88.8 89.8 87.9 89.1 90.3 92.1 90.7 91.9 90.9 91.5 92.0 88.2 92.1 90.8 90.9 88.3 87.0 88.8 90.2 88.4 88.3 89.8 91.3 90.1 91.3 90.8 90.2 92.8 86.7 90.0 90.0 88.4 90.8 91.3 89.8 90.9 87.3 89.9 90.2 92.5 91.3 92.8 91.6 93.4 92.6 91.8 93.7 92.1 93.6
Hib (3 doses or more)k 89.4 91.4 90.1 91.8 92.8 89.5 91.6 92.4 90.9 92.9 91.0 90.8 88.6 80.4 89.4 93.0 91.1 85.9 91.0 90.3 90.7 91.9 87.1 88.3 90.0 89.6 91.6 89.9 89.4 90.1 77.7 87.0 91.4 89.1 92.8 93.7 89.6 94.1 93.4 91.3 93.9 94.6 92.3 94.8 93.4 92.2 93.6 83.9 91.9 95.1 94.0
Hepatitis B (3 doses or more) 81.9 82.0 83.7 86.5 89.2 84.9 88.0 91.6 90.8 92.7 91.5 91.2 92.1 91.6 92.1 92.1 89.7 77.8 81.9 86.1 85.6 88.6 84.7 88.6 91.5 89.2 92.7 91.6 91.6 91.6 91.8 90.8 93.1 87.3 85.0 84.3 82.8 89.9 90.2 85.3 87.7 92.2 92.1 94.1 92.5 91.0 95.8 92.8 93.6 91.8 92.5
Varicella (1 dose or more)l 8.6 20.8 42.4 57.6 67.3 75.3 82.7 85.4 86.3 90.6 89.1 89.8 90.4 88.2 91.5 91.2 90.4 15.7 40.1 57.1 60.2 71.3 79.7 83.7 85.2 91.0 89.2 89.3 91.1 87.5 89.0 91.3 88.9 12.9 27.1 44.4 60.4 72.1 77.1 83.6 86.1 87.4 90.8 89.8 90.8 92.7 91.5 93.7 91.3 92.1
PCV (3 doses or more)m 33.9 62.3 68.2 79.6 82.9 89.5 90.9 91.5 92.6 93.4 91.2 30.2 61.3 66.5 76.8 82.2 87.8 92.5 89.7 89.9 93.1 89.8 37.5 63.7 69.6 82.2 84.5 91.4 95.7 95.4 95.5 94.2 92.9
PCV (4 doses or more)m 46.2 60.5 70.3 76.4 73.2 79.7 81.3 77.1 42.7 56.6 66.1 74.9 70.0 75.0 80.6 73.9 48.1 64.8 74.4 82.3 78.1 83.8 83.3 81.7
Hepatitis A (2 doses or more)n 39.7 41.3 48.6 50.9 52.0 38.7 40.1 49.3 46.8 48.2 40.7 42.5 47.9 56.9 56.7
Rotavirus (2 doses or more)o 38.0 52.7 62.5 60.4 32.6 45.7 56.8 55.1 44.6 58.6 68.9 68.0
Hispanic
Combined Series (4:3:1:3:3:1:4)d 67.1 72.0 69.5 67.8 65.5 70.5 67.9 68.1 68.2 72.2 71.1 68.3
Combined series (4:3:1:3:3:1)e 66.0 71.3 75.9 75.6 77.0 78.0 77.7 72.8 77.2 77.9 66.0 73.1 75.0 75.6 76.4 77.7 74.9 71.2 76.2 77.9 65.5 70.3 77.5 74.8 78.3 78.5 80.5 73.6 77.2 78.0
Combined series (4:3:1:3:3)f 63.7 65.7 68.7 69.6 68.5 74.1 72.7 77.0 79.7 78.8 79.7 79.8 79.4 73.9 78.6 62.4 62.2 65.1 68.0 66.2 69.8 71.8 76.8 78.9 78.3 78.3 79.0 76.6 72.3 77.3 64.1 69.8 73.3 72.9 70.3 75.7 72.9 78.3 81.7 79.1 81.6 80.9 82.1 74.7 78.8
Combined series (4:3:1:3)g 71.1 72.6 75.3 74.9 72.7 77.0 75.5 78.7 81.2 81.2 81.3 81.5 80.7 74.7 80.0 81.9 75.4 68.2 69.6 72.9 73.3 69.9 73.1 74.8 77.6 79.8 80.9 80.1 80.9 77.5 73.0 78.6 82.0 74.8 72.7 76.7 79.1 78.4 74.1 78.8 75.6 80.6 83.5 81.9 83.2 82.5 83.9 75.3 80.8 81.9 76.9
DTP (4 doses or more)h 77.2 77.7 80.5 80.2 78.6 82.5 79.2 81.9 84.1 83.6 84.5 83.8 84.9 82.9 84.4 84.1 80.8 74.0 74.9 79.0 77.9 76.1 79.1 77.9 81.1 82.5 82.5 82.7 82.9 82.2 86.6 82.0 84.2 80.7 77.5 80.6 83.2 82.4 79.9 83.1 79.7 83.5 86.0 84.9 86.3 85.2 87.7 83.0 85.7 83.9 81.3
Polio (3 doses or more)i 89.4 89.7 88.9 89.4 87.9 90.7 90.4 90.1 91.2 92.3 93.3 93.0 94.3 92.5 93.8 93.8 92.5 88.0 88.4 90.1 88.8 87.7 89.6 89.3 89.3 90.1 91.5 93.0 95.3 92.5 93.5 93.2 94.8 92.1 89.8 90.2 90.3 89.9 86.9 91.1 90.7 91.5 92.2 92.3 93.4 90.4 96.3 91.5 94.0 93.2 93.4
MMR (1 dose or more)j 88.2 88.4 91.0 90.2 90.0 92.1 90.5 92.7 93.2 91.1 92.0 92.6 92.8 89.3 92.9 92.4 90.7 87.4 85.2 90.4 89.9 90.0 90.5 90.8 93.4 92.1 89.5 92.8 92.9 92.8 91.0 92.6 93.7 91.0 89.0 89.5 92.3 91.3 90.0 92.7 89.0 93.4 93.5 91.4 91.9 92.1 92.6 88.4 92.7 91.0 90.7
Hib (3 doses or more)k 88.5 90.0 91.7 92.0 91.1 92.5 92.4 93.1 92.6 94.2 93.9 93.5 91.9 86.4 92.0 94.4 93.5 87.1 89.0 91.8 90.7 87.7 91.3 93.1 91.7 91.8 93.6 93.5 93.9 90.1 85.0 90.4 94.9 93.5 90.3 92.3 93.5 95.1 93.3 94.4 92.2 95.1 94.4 93.9 93.9 92.9 93.6 87.9 93.4 95.2 93.7
Hepatitis B (3 doses or more) 80.8 81.2 85.7 87.3 88.2 89.8 89.5 91.2 91.9 92.7 93.6 93.6 93.7 92.6 92.5 91.5 89.4 79.9 78.8 83.1 86.5 86.7 88.1 89.0 90.7 91.3 91.5 93.2 94.5 91.6 92.6 92.4 93.0 90.0 81.1 84.4 88.3 88.9 89.7 91.0 88.9 92.8 92.9 92.8 93.9 92.6 95.8 92.4 92.4 91.0 88.3
Varicella (1 dose or more)l 7.6 22.4 46.9 60.5 70.2 80.3 81.8 85.7 89.1 89.2 89.6 90.6 91.8 90.7 92.3 92.0 90.9 6.3 17.6 44.0 58.6 69.9 80.7 82.4 87.8 88.1 88.4 90.5 91.2 91.1 89.8 91.6 92.1 90.3 11.2 25.3 48.8 61.7 69.8 81.8 80.6 84.7 89.4 88.8 90.5 89.3 92.7 90.8 92.1 92.0 92.0
PCV (3 doses or more)m 37.4 65.5 70.4 83.5 88.9 91.0 94.1 92.7 93.4 94.3 92.4 35.1 65.1 71.2 80.0 87.7 91.6 92.5 93.8 92.8 95.3 92.7 37.6 67.4 71.4 86.0 89.8 90.3 95.7 91.9 93.3 94.2 92.3
PCV (4 doses or more)m 50.5 67.4 75.4 78.6 80.6 83.9 84.6 82.1 44.7 64.9 77.5 74.9 84.7 81.9 84.1 81.0 53.8 70.2 73.3 82.3 82.1 85.1 85.4 84.1
Hepatitis A (2 doses or more)n 44.7 49.3 57.0 56.3 54.4 43.9 52.1 56.3 57.8 52.5 44.6 52.1 56.7 54.7 57.5
Rotavirus (2 doses or more)o 43.7 60.5 68.3 70.0 42.0 57.2 66.1 70.0 46.0 64.0 71.4 72.1
— Not available.
a Based on family income and household size using Census Bureau poverty thresholds for the year of data collection.
b From 1996 to 2001, the 1977 Office of Management and Budget (OMB) standards for data on race and ethnicity were used to classify persons into one of the following racial groups: White, Black, American Indian or Alaskan Native, or Asian or Pacific Islander. Beginning in 2002, the revised 1997 OMB Standards for Data on Race and Ethnicity were used. Persons could select one or more from the following racial groups: White, Black or African American, American Indian or Alaska Native, Asian, or Native Hawaiian or Other Pacific Islander. Persons of Hispanic origin may be of any race. Included in the total but not shown separately are American Indian or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander, and "Two or more races," due to the small sample size. Data on race and Hispanic origin are collected separately but combined for reporting.
c The 2009 series estimates were affected by the Hib vaccine shortage and the interim Advisory Committee on Immunization Practices (ACIP) recommendation to suspend the booster dose for healthy children from December 2007 to June 2009, a time when most children in the 2009 National Immunization Survey would have been eligible for the booster dose of the Hib vaccine. Coverage with the full series of Hib vaccine increased in 2010, suggesting that children received the booster dose as Hib vaccine supplies became adequate starting in July 2009.
d The 4:3:1:3:3:1:4 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; 3 doses (or more) of hepatitis B vaccines; 1 dose (or more) of varicella vaccine and 4 doses (or more) of heptavalent pneumococcal conjugate vaccine (PCV) The collection of coverage estimates for this series began in 2009.
e The 4:3:1:3:3:1 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; 3 doses (or more) of hepatitis B vaccines; and 1 dose (or more) of varicella vaccine. The collection of coverage estimates for this series began in 2002. See footnote c concerning changes to Hib vaccine coverage in 2009.
f The 4:3:1:3:3 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; and 3 doses (or more) of hepatitis B vaccines. See footnote c concerning changes to Hib vaccine coverage in 2009.
g The 4:3:1:3 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; and 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines. See footnote c concerning changes to Hib vaccine coverage in 2009.
h Diphtheria, tetanus toxoids, and pertussis vaccine (4 doses or more of any diphtheria, tetanus toxoids, and pertussis vaccines, including diphtheria and tetanus toxoids, and any acellular pertussis vaccine).
i Poliovirus vaccine (3 doses or more).
j Measles-mumps-rubella (MMR) vaccine (1 dose or more) was used beginning in 2005. The previous coverage years reported measles-containing vaccines.
k Haemophilus influenzae type b (Hib) vaccine (3 doses or more) regardless of brand type.
l Varicella vaccine (1 dose or more) is recommended at any visit at or after age 12 months for susceptible children (i.e., those who lack a reliable history of chickenpox).
m The heptavalent pneumococcal conjugate vaccine (PCV) is recommended for all children aged less than 5 years. The series consists of doses at ages 2, 4, and 6 months, and a booster dose at ages 12–15 months.
n Hepatitis A vaccine (2 doses or more) is recommended for all children ages 12–23 months. ACIP expanded this recommendation in May 2006. National Immunization Survey (NIS) data prior to 2008 for children ages 19–35 months are not available for Hepatitis A vaccine.
o Estimates of rotavirus coverage reflect early vaccinations, primarily among children born during the first 2 years of the licensure of rotavirus vaccine.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey.